Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997, 349 (9063): 1436-1442. 10.1016/S0140-6736(96)07495-8.
Article
CAS
PubMed
Google Scholar
Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD: Healthy life expectancy in 191 countries, 1999. Lancet. 2001, 357 (9269): 1685-1691. 10.1016/S0140-6736(00)04824-8.
Article
CAS
PubMed
Google Scholar
Linton MF, Fazio S: A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol. 2003, 92 (1A): 19i-26i. 10.1016/S0002-9149(03)00505-8.
Article
PubMed
Google Scholar
Gotto AMJ: How do we achieve optimal cardiovascular risk reduction?. Clin Cardiol. 2001, 24 (8 Suppl): III8-12.
PubMed
Google Scholar
Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003, 115 (1): 41-46. 10.1016/S0002-9343(03)00158-X.
Article
PubMed
Google Scholar
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002, 359 (9311): 995-1003. 10.1016/S0140-6736(02)08089-3.
Article
CAS
PubMed
Google Scholar
Zidek W, Dusing R, Haller H, Middeke M, Paul M, Schmieder R, Schrader J: New recommendations of the German Hypertension League for the drug treatment of hypertension. Dtsch Med Wochenschr. 2003, 128: 2468-2469. 10.1097/00004872-200306000-00001.
Article
CAS
PubMed
Google Scholar
Guidelines committee: European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21: 1011-1053.
Article
Google Scholar
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2571. 10.1001/jama.289.19.2560.
Article
CAS
PubMed
Google Scholar
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC, Rubin HR: Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement. JAMA. 1999, 282 (15): 1458-1465. 10.1001/jama.282.15.1458.
Article
CAS
PubMed
Google Scholar
Faulhaber HD, Luft FC: Treatment of high blood pressure in Germany. Am J Hypertens. 1998, 11 (6 Pt 1): 750-753. 10.1016/S0895-7061(98)00068-5.
Article
CAS
PubMed
Google Scholar
Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Göke B, Lehnert H, Tschöpe D, Krause P, Höfler M, Pfister H, Bramlage P, Unger T: High prevalence and poor control of hypertension in primary care: cross sectional study. J Hypertens. 2004, 22: 479-486. 10.1097/00004872-200403000-00009.
Article
CAS
PubMed
Google Scholar
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J Am Med Ass. 2003, 289 (18): 2363-2369. 10.1001/jama.289.18.2363.
Article
Google Scholar
Nash IS, Nash DB, Fuster V: Do cardiologists do it better?. J Am Coll Cardiol. 1997, 29 (3): 475-478. 10.1016/S0735-1097(96)00528-1.
Article
CAS
PubMed
Google Scholar
Baessler A, Fischer M, Hengstenberg C, Holmer S, Hubauer U, Huf V, Mell S, Klein G, Riegger G, Schunkert H: [Inpatient rehabilitation improves implementation of therapeutic guidelines for secondary prevention in patients with coronary heart disease]. Z Kardiol. 2001, 90 (9): 646-654. 10.1007/s003920170112.
Article
CAS
PubMed
Google Scholar
Gubner R, Ungerleider HE: Electrocardiographic criteria of left ventricular hypertrophy. Arch Intern Med. 1943, 72: 196-209.
Article
Google Scholar
Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949, 37: 161-186. 10.1016/0002-8703(49)90562-1.
Article
CAS
PubMed
Google Scholar
Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994, 90 (4): 1786-1793.
Article
CAS
PubMed
Google Scholar
Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977, 55 (4): 613-618.
Article
CAS
PubMed
Google Scholar
Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984, 4 (6): 1222-1230.
Article
CAS
PubMed
Google Scholar
Diller PM, Smucker DR, David B, Graham RJ: Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting. Arch Fam Med. 1999, 8 (5): 414-420. 10.1001/archfami.8.5.414.
Article
CAS
PubMed
Google Scholar
Cleveland WS, Devlin SJ: Locally Weighted Regression. An Approach to Regression Analysis by Local Fitting. J Am Stat Assoc. 1988, 83: 596-610. 10.2307/2289282.
Article
Google Scholar
Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika. 1983, 70: 41-55. 10.2307/2335942.
Article
Google Scholar
Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997, 127 (8 Pt 2): 757-763.
Article
CAS
PubMed
Google Scholar
Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001, 104 (14): 1615-1621.
Article
CAS
PubMed
Google Scholar
Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ: Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999, 353 (9169): 2008-2013. 10.1016/S0140-6736(98)07614-4.
Article
CAS
PubMed
Google Scholar
Hasford J, Mimran A, Simons WR: A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens. 2002, 16 (8): 569-575. 10.1038/sj.jhh.1001451.
Article
CAS
PubMed
Google Scholar
Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD: Persistence with treatment for hypertension in actual practice. Can Med Assoc J. 1999, 160 (1): 31-37.
CAS
Google Scholar
Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003, 326 (7404): 1427-1420. 10.1136/bmj.326.7404.1427.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA: Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998, 339 (27): 1957-1963. 10.1056/NEJM199812313392701.
Article
CAS
PubMed
Google Scholar
Myers MG: Compliance in hypertension: Why don't patients take their pills?. Can Med Assoc J. 1999, 160 (1): 64-65.
CAS
Google Scholar
Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med. 2001, 135 (9): 825-834.
Article
CAS
PubMed
Google Scholar
Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, Sharma AM, Wittchen HU: Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004, 60 (2): 135-142. 10.1007/s00228-004-0731-6.
Article
CAS
PubMed
Google Scholar
Furstenberg T, Bunzemeier H, Roeder N, Reinecke H: [Cardiovascular medicine in the German diagnosis-related group--(G-DRG) system 2005]. Z Kardiol. 2005, 94 (5): 360-370. 10.1007/s00392-005-0234-1.
Article
CAS
PubMed
Google Scholar
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998, 351 (9118): 1755-1762. 10.1016/S0140-6736(98)04311-6.
Article
CAS
PubMed
Google Scholar
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, the RENAAL Study Investigators: Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med. 2001, 345 (12): 861-869. 10.1056/NEJMoa011161.
Article
CAS
PubMed
Google Scholar
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001, 345 (12): 851-860. 10.1056/NEJMoa011303.
Article
CAS
PubMed
Google Scholar
Nash IS, Corrato RR, Dlutowski MJ, O'Connor JP, Nash DB: Generalist versus specialist care for acute myocardial infarction. Am J Cardiol. 1999, 83 (5): 650-654. 10.1016/S0002-9149(98)00961-8.
Article
CAS
PubMed
Google Scholar
Donohoe MT: Comparing generalist and specialty care: discrepancies, deficiencies, and excesses. Arch Intern Med. 1998, 158 (15): 1596-1608. 10.1001/archinte.158.15.1596.
Article
CAS
PubMed
Google Scholar
Schreiber TL, Elkhatib A, Grines CL, O'Neill WW: Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol. 1995, 26 (3): 577-582. 10.1016/0735-1097(95)00214-O.
Article
CAS
PubMed
Google Scholar
Chin MH, Friedmann PD, Cassel CK, Lang RM: Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997, 12 (9): 523-530. 10.1046/j.1525-1497.1997.07105.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guadagnoli E, Normand SL, DiSalvo TG, Palmer RH, McNeil BJ: Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med. 2004, 117 (6): 371-379. 10.1016/j.amjmed.2004.04.013.
Article
PubMed
Google Scholar
Pearson TA, Peters TD: The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997, 80 (8B): 45H-52H.
Article
CAS
PubMed
Google Scholar
Fonarow GC: The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes. Rev Cardiovasc Med. 2002, 3 Suppl 3: S2-S10.
PubMed
Google Scholar
Anonymous: ASH Specialists Program. Available at http://www.ash-us.org/specialist_program/index.htm. Last access on 20 September 2006.